American Century ETF Trust - Avantis International Large Cap Value ETF (AVIV) Stock Price

67.66 ▲ +0.925 (+1.39%)
Open: 67.29 Vol: 45.67K Day's range: 67.02 - 67.7614 Nov 21, 16:00 EST
IEX quote, 15 minutes delayed during trading hours. Login or Signup to see real-time data
Free Stock Screener
Loading chart ...
AVIV Technical Analysis
5 mins 30 mins Hourly Daily Weekly
BUY NEUTRAL NEUTRAL SELL BUY
  5 mins 30 mins Hourly Daily Weekly
MA5 67.43▲ 67.33▲ 67.26▲ 67.69▼ 68.23▼
MA10 67.18▲ 67.18▲ 67.24▲ 68.57▼ 67.75▼
MA20 67.36▲ 67.44▲ 67.52▲ 68.30▼ 66.16▲
MA50 68.00▼ 68.37▼ 68.59▼ 67.81▼ 60.61▲
MA100 68.59▼ 68.39▼ 68.43▼ 66.05▲ 56.99▲
MA200 68.48▼ 68.15▼ 68.08▼ 62.23▲ 51.98▲
  5 mins 30 mins Hourly Daily Weekly
MACD 0.104▲ 0.079▲ 0.066▲ -0.208▼ -0.140▼
RSI 52.723▲ 49.499▼ 48.014▼ 46.800▼ 61.308▲
STOCH 83.781▲ 49.285     42.852     27.040     70.583    
WILL %R -11.707▲ -36.042     -36.042     -73.118     -47.958    
CCI 111.792▲ 52.387     43.548     -68.483     48.222    
Latest Filters Detected On AVIV
CDL $AVIV Harami Candlestick Pattern Detected Set Alert
American Century ETF Trust - Avantis International Large Cap Value ETF News
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December
Friday, November 21, 2025 02:22 PM
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and other members of ...
Teva Pharmaceutical Industries Ltd: Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi's 2025 Global ...
Friday, November 21, 2025 01:49 PM
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced that Richard Francis, Teva's President and CEO, and other members of executive ...
Nasus Pharma Announces Approval from Health Canada to Initiate Planned Phase 2 Clinical Study of NS002 Intranasal Epinephrine Powder
Friday, November 21, 2025 01:12 PM
Positive Regulatory Response Marks Important Milestone for NS002 Development ProgramTEL AVIV, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Nasus Pharma Ltd. (NYSE: NSRX) (“Nasus Pharma” or the “Company”), a ...
AVIV historical stock data
date open high low close volume
21/11/25 67.29 67.7614 67.02 67.66 45,674
20/11/25 68.31 68.31 66.735 66.735 51,638
19/11/25 67.88 68.08 67.49 67.72 63,900
18/11/25 67.73 68.07 67.47 67.84 51,100
17/11/25 68.92 69.11 68.28 68.48 74,300
14/11/25 68.97 69.405 68.77 69.23 55,500
13/11/25 70.09 70.10 69.3172 69.38 68,645
12/11/25 69.78 70.176 69.78 70.06 53,900
11/11/25 69.22 69.60 69.22 69.47 21,800
10/11/25 68.70 69.15 68.59 69.11 38,600
Quote Details
52wk Low:49.844
52wk High:70.176
Vol:45.67K
Avg Vol(3m):851K
1Y Chng:+24.03%
1M Chng:+1.06%
Add to Watch List
More Information
Sector N/A
Index N/A
Market Cap. 0.00